Conference Report: The FutuRE oF MinimalLy InvasivE GI and Capsule DiagnosTics (REFLECT), September 2025
Diagnostics · 27.04.2026 · 16 (9) · 1315
DOI: 10.3390/diagnostics16091315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 27.04.2026. Verfasst von Alexandra Agache und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Odense University Hospital, 5700 Svendborg, Denmark. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Capsule endoscopy (CE) is evolving from a primarily small-bowel imaging modality into a broader diagnostic platform that increasingly incorporates artificial intelligence (AI), robotic technologies, biosensing capabilities, and decentralized models of care. The REFLECT symposium brought together an international, multidisciplinary audience of clinicians, engineers, scientists, and healthcare stakeholders to critically evaluate the present and future role of CE across a range of gastrointestinal (GI) applications, including inflammatory bowel disease, GI bleeding, coeliac disease, and colorectal cancer screening. Discussions explored the clinical impact of panenteric and colon capsule endoscopy, the potential of AI to enhance diagnostic performance and streamline workflows, innovations in capsule hardware, and the design of patient-centred diagnostic pathways. While conventional endoscopy continues to serve as the benchmark in many clinical scenarios, CE was recognized for its ability to improve access, acceptability, and scalability when deployed in appropriately selected populations. The symposium also identified key barriers to broader implementation, such as reinvestigation rates, absence of standardized quality indicators, limited real-world evidence for AI tools, and ongoing economic and environmental challenges. Overall, the meeting highlighted the importance of gradual, evidence-driven integration of CE, supported by robust validation, standardized metrics, close clinician-engineer collaboration, and meaningful incorporation of patient experience, to support the development of a safe, equitable, and sustainable pathway.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Odense University Hospital, 5700 Svendborg, Denmark.
- Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark.
- Department 10 General Surgery, University of Medicine and Pharmacy 'Carol Davila', 050474 Bucharest, Romania.
- Department of Gastroenterology, Pomeranian Medical University, 70-111 Szczecin, Poland.
ORCID-Profile: Alexandra Agache, Niels Gellert Olesen, Jakob Frederik Frøkjær Justsen, Anastasios Koulaouzidis
Zitieren
APA
Agache, A., Olesen, N. G., Skifte, A. S., Justsen, J. F. F., & Koulaouzidis, A. (2026). Conference Report: The FutuRE oF MinimalLy InvasivE GI and Capsule DiagnosTics (REFLECT), September 2025. Diagnostics, 16(9), 1315. https://doi.org/10.3390/diagnostics16091315
Vancouver
Agache A, Olesen NG, Skifte AS, Justsen JFF, Koulaouzidis A. Conference Report: The FutuRE oF MinimalLy InvasivE GI and Capsule DiagnosTics (REFLECT), September 2025. Diagnostics. 2026;16(9):1315. doi:10.3390/diagnostics16091315
BibTeX
@article{Agache2026,
author = {Agache, Alexandra and Olesen, Niels Gellert and Skifte, Asta Slott and Justsen, Jakob Frederik Frøkjær and Koulaouzidis, Anastasios},
title = {Conference Report: The FutuRE oF MinimalLy InvasivE GI and Capsule DiagnosTics (REFLECT), September 2025},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {9},
pages = {1315},
doi = {10.3390/diagnostics16091315}
}
EUVIMED